Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 320.9 $ 415.3
Receivables, net of allowance for doubtful accounts 96.2 68.9
Inventories 513.1 475.4
Prepaid expenses and other current assets 172.7 184.1
Total current assets 1,102.9 1,143.7
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization 465.8 460.2
Operating lease right-of-use assets 181.8 185.7
Marketing-related intangibles and other intangible assets, net 316.5 312.3
Goodwill 101.0 87.7
Deferred income tax assets 427.8 398.6
Other assets 140.3 139.9
Total assets 2,736.1 2,728.1
Current liabilities:    
Accounts payable 91.8 70.0
Royalty overrides 328.8 334.1
Current portion of long-term debt 168.0 283.5
Other current liabilities 505.7 542.8
Total current liabilities 1,094.3 1,230.4
Long-term debt, net of current portion 1,973.5 1,976.6
Non-current operating lease liabilities 165.4 169.5
Other non-current liabilities 157.3 152.7
Total liabilities 3,390.5 3,529.2
Commitments and contingencies
Shareholders' deficit:    
Common shares, $0.0005 par value; 2.0 billion shares authorized; 103.1 million (2025) and 101.2 million (2024) shares outstanding 0.1 0.1
Paid-in capital in excess of par value 294.3 278.2
Accumulated other comprehensive loss (246.6) (271.4)
Accumulated deficit (708.3) (808.0)
Total Herbalife shareholders' deficit (660.5) (801.1)
Noncontrolling interest 6.1 0.0
Total shareholders' deficit (654.4) (801.1)
Total liabilities and shareholders' deficit $ 2,736.1 $ 2,728.1